Redwood Park Advisors »

Acrivon Therapeutics shares owned by Redwood Park Advisors

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Redwood Park Advisors from 13F filings

Historical chart of Redwood Park Advisors investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Redwood Park Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Redwood Park Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $905 500 1.81
2025-06-30 $595 500 1.19

More positions owned by Redwood Park Advisors

Goldman Sachs Etf Tr Acces Treasury (GBIL)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Msci Usa Min Vol (USMV)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Apple (AAPL)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Flexshares Tr Mornstar Upstr (GUNR)
Ishares Tr Msci Eafe Etf (EFA)
Adobe Systems Incorporated (ADBE)

View all positions for Redwood Park Advisors

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
UBS Group
Vanguard Group
Renaissance Technologies
Acorn Capital Advisors
BlackRock
Two Sigma Investments
Jane Street
Geode Capital Management
Millennium Management
Marshall Wace
Two Sigma Advisers

View all funds holding Acrivon Therapeutics